Anti-Human CDH17 Recombinant Antibody (CAT#: TAB-152CL)
Recombinant Humanized monoclonal antibody expressed in CHO binding to Human CDH17. The antibodiess specifically bind to Cadherin-17 with high affinity can be used for treating various cancers, including colorectal cancer.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

(Immunofluorescent staining of human cell line CACO-2 shows localization to cell junctions.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/23616/1030_A11_3_selected.jpg

(High expression)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/23614/52777_A_9_2_val_selected.jpg

(Endocrine cells Staining: High Intensity: Strong Enterocytes Staining: High Intensity: Strong Quantity:>75% Enterocytes - Goblet cells Staining: High Intensity: Strong Quantity:>75% Paneth cells Staining: High Intensity: Strong)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/23616/52785_A_6_2.jpg

(Endocrine cells Staining: High Intensity: Strong Enterocytes Staining: High Intensity: Strong Quantity:>75% Enterocytes - Goblet cells Staining: High Intensity: Strong Quantity:>75%)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/23616/52785_A_9_3.jpg

(Cells in seminiferous ducts Staining: Low Intensity: Weak Quantity: 75%-25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/23616/52785_A_5_6.jpg

(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000079112-CDH17
Specifications
- Derivation
- Humanized
- Type
- Antibody
- Species Reactivity
- Human
- Related Disease
- Cancer
Product Property
- Purity
- >95% as judged by SDS-polyacrylamide gel electrophoresis
- Storage
- 4 °C, -20°C if preferred
Target
- Alternative Names
- CDH17; cadherin 17, LI cadherin (liver-intestine); HPT1; CDH16; HPT-1; cadherin 17; cadherin-1
- Gene ID
- 1015
- UniProt ID
- Q12864
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "CDH17"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-1415CL-S(P) | Mouse Anti-CDH17 Recombinant Antibody; scFv Fragment (TAB-1415CL-S(P)) | ELISA | Mouse scFv |
TAB-1416CL-S(P) | Mouse Anti-CDH17 Recombinant Antibody; scFv Fragment (TAB-1416CL-S(P)) | ELISA | Mouse scFv |
TAB-1417CL-S(P) | Mouse Anti-CDH17 Recombinant Antibody; scFv Fragment (TAB-1417CL-S(P)) | ELISA | Mouse scFv |
TAB-1418CL-S(P) | Mouse Anti-CDH17 Recombinant Antibody; scFv Fragment (TAB-1418CL-S(P)) | ELISA | Mouse scFv |
TAB-1419CL-S(P) | Mouse Anti-CDH17 Recombinant Antibody; scFv Fragment (TAB-1419CL-S(P)) | ELISA | Mouse scFv |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-152CL. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: WB, ELISA, FuncS
Application: Neut, ELISA, Inhib, ICC, WB
Application: WB, ELISA, FC, IHC, IP
Application: Neut, FC, IHC-Fr, IP, BA
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, IF, Block, FuncS
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.